These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6034976)

  • 1. Effect of 6-alpha-methyl-17-alpha-hydroxyprogesterone on urinary excretion of luteinizing hormone.
    Mishell DR
    Am J Obstet Gynecol; 1967 Sep; 99(1):86-90. PubMed ID: 6034976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of antagonistic analogs of LH-RH as a contraceptive method in the female.
    Schally AV
    Res Front Fertil Regul; 1983 Jul; 2(5):1-16. PubMed ID: 12179624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
    Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of bleeding patterns and resumption of fertility following discontinuation of a long acting injectable contraceptive.
    Gardner JM; Mishell DR
    Fertil Steril; 1970 Apr; 21(4):286-91. PubMed ID: 5508497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogenic activity in women receiving an injectable progestogen for contraception.
    Mishell DR; Kharma KM; Thorneycroft IH; Nakamura RM
    Am J Obstet Gynecol; 1972 Jun; 113(3):372-6. PubMed ID: 4637029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiovulatory effect of ICI 33,828 (methallibure) without affecting prolactin release in normal rats.
    Deis RP; Vermouth NT
    Neuroendocrinology; 1974; 13(6):351-6. PubMed ID: 4858373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL; Sweeting VM; Hillier H; Baird DT
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect on hormone excretion patterns of depot medroxyprogesterone acetate used as a contraceptive preparation.
    Bloch B
    S Afr J Obstet Gynaecol; 1972; 10():3-8. PubMed ID: 12276419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case for concern?
    Gartland A
    Nurs Times; 1983 May 4-10; 79(18):10-1. PubMed ID: 6222288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA.
    Ortiz A; Hirol M; Stanczyk FZ; Goebelsmann U; Mishell DR
    J Clin Endocrinol Metab; 1977 Jan; 44(1):32-8. PubMed ID: 833262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medroxyprogesterone acetate, estradiol, FSH and LH in peripheral blood after intramuscular administration of Depo-ProveraR to women.
    Jeppsson S; Johansson
    Contraception; 1976 Oct; 14(4):461-69. PubMed ID: 975831
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary hormone excretion patterns during low-dose progestogen administration.
    Varga L; Tamme E
    J Int Med Res; 1975; 3(2):63-72. PubMed ID: 1140508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteinizing hormone releasing hormone agonist for contraception in breast feeding women.
    Fraser HM; Dewart PJ; Smith SK; Cowen GM; Sandow J; McNeilly AS
    J Clin Endocrinol Metab; 1989 Nov; 69(5):996-1002. PubMed ID: 2507572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraception by means of a silastic vaginal ring impregnated with medroxyprogesterone acetate.
    Mishell DR; Talas M; Parlow AF; Moyer DL
    Am J Obstet Gynecol; 1970 May; 107(1):100-7. PubMed ID: 5443056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Doses-related effects of lynestrenol on ovulation (author's transl)].
    Pizarro MA; Thomas K; Ferin J
    Reproduccion; 1976; 3(3-4):193-205. PubMed ID: 802117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contraceptive effect of varying dosages of progestogen in silastic vaginal rings.
    Mishell DR; Lumkin ME
    Fertil Steril; 1970 Feb; 21(2):99-103. PubMed ID: 5414562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pituitary reserve for gonadotrophins and prolactin in women under long-term use of depo-medroxyprogesterone acetate (DMPA) as a contraceptive.
    Mukasa FR; Sekadde-kigondu CB; Mati JK; Njoroge JK
    J Obstet Gynaecol East Cent Africa; 1982 Dec; 1(4):160-3. PubMed ID: 12313677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depo Provera: still controversial.
    Wren LM
    Int Health News; 1988 Feb; 9(2):2-3, 8. PubMed ID: 12179873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.